Benitec Biopharma
Financial ratios & Valuation

Forward Multiples (2026 – 2028)

202620272028
Price/Earnings ratio
-2.69-3.0329.12
Price/Sales ratio
3.66K1.062.58
Earnings per Share (EPS)
$-4.65$-4.13$0.43

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-9.11-0.65-4.81-3.304.81-0.97-1.32-0.51-0.28-1.35-0.30-0.30
Price/Sales ratio
96.9934.9746.7962.071.2283.27309.41129.8575.01136.4693.881.22
Price/Book Value ratio
4.390.861.272.050.830.780.913.2827.850.620.640.78
Price/Cash Flow ratio
-8.29-0.59-2.53-3.302.88-1.07-1.42-0.59-0.31-1.51-0.32-0.32
Price/Free Cash Flow ratio
-7.97-0.59-2.49-3.283.14-1.05-1.39-0.59-0.31-1.50-0.32-0.32
Price/Earnings Growth ratio
0.25-0.000.05-0.05-0.030.000.020.010.000.02-0.00-0.03
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
96.29%70.04%53.58%27.25%96.23%-176.35%-108.47%87.67%-408%50%62.90%-176.35%
Operating Profit Margin
-1607.59%-7204.20%-3536.22%-1877.74%17.69%-8537.11%-23044.06%-24457.53%-25441.33%-10412.03%-29658.06%-8537.11%
Pretax Profit Margin
-1064.66%-5340.09%-970.99%-1877.42%25.33%-8529.89%-23528.81%-24942.46%-26082.66%-10356.48%-30396.77%-8529.89%
Net Profit Margin
-1064.66%-5340.09%-970.99%-1877.42%25.33%-8557.73%-23357.62%-25427.39%-26082.66%-10069.90%-30396.77%-8557.73%
Effective Tax Rate
-9.30%48.64%-4.79%-0.01%-30.14%-0.32%0.72%-1.94%-0.01%2.76%N/A-30.14%
Return on Assets
-45.09%-124.57%-25.10%-54.54%14.92%-71.64%-64.46%-310.76%-438.21%-41.66%-158.30%-71.64%
Return On Equity
-48.19%-131.53%-26.45%-62.09%17.30%-81.08%-68.87%-644.06%-9684.15%-46.03%-221.65%-81.08%
Return on Capital Employed
-72.77%-177.28%-96.19%-61.95%12.08%-79.23%-67.94%-518.86%-3926.13%-47.56%-195.28%-79.23%
Liquidity Ratios
Current Ratio
15.2618.7219.698.207.109.5115.05N/AN/AN/A4.409.51
Quick Ratio
13.5718.5819.778.207.108.6815.051.900.9310.494.268.68
Cash ratio
13.2617.6115.446.315.958.6214.441.600.6210.334.238.62
Days of Sales Outstanding
N/AN/A2.74K107.3881.79222.01154.6615N/A386.96400.3281.79
Days of Inventory outstanding
25.31K391.25-113.62N/A0.001.29KN/A0.0712.45N/AN/A1.29K
Operating Cycle
25.31K391.252.63K107.3881.791.51K154.6615.0712.45386.9698.7081.79
Days of Payables Outstanding
6.93K1.41K233.49469.401.26K383.97813.0817.11K1.09K4.56KN/A383.97
Cash Conversion Cycle
18.37K-1.02K2.39K-362.01-1.17K1.12K-658.42-17.09K-1.07K-4.17K400.32-1.17K
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.24N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.32N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.04N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.07N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-483.89N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-26.51N/A
Company Equity Multiplier
1.061.051.051.131.151.131.062.0722.091.101.321.15
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-11.68-58.31-18.44-18.770.42-77.68-217.49-217.79-240.16-89.82-292.98-77.68
Free Cash Flow / Operating Cash Flow Ratio
1.031.011.011.000.911.011.011.001.001.001.000.91
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-26.51N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-69.06N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A